FDA Warning Letter — Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd. on April 19, 2018 (Lijiang, China). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Lijiang Yinghua Biochemical and Pharmaceutical Co., Ltd.
- Date
- April 19, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Lijiang (China)